Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Net Income (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Net Income for 16 consecutive years, with -$6.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income fell 162.81% to -$6.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.6 million, a 67.69% decrease, with the full-year FY2024 number at $42.1 million, down 34.06% from a year prior.
  • Net Income was -$6.7 million for Q3 2025 at Usana Health Sciences, down from $10.4 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $40.4 million in Q4 2021 to a low of -$6.7 million in Q3 2025.
  • A 5-year average of $17.3 million and a median of $16.5 million in 2024 define the central range for Net Income.
  • Peak YoY movement for Net Income: soared 36.66% in 2021, then plummeted 162.81% in 2025.
  • Usana Health Sciences' Net Income stood at $40.4 million in 2021, then tumbled by 68.29% to $12.8 million in 2022, then soared by 31.04% to $16.8 million in 2023, then plummeted by 73.26% to $4.5 million in 2024, then tumbled by 248.57% to -$6.7 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Net Income are -$6.7 million (Q3 2025), $10.4 million (Q2 2025), and $9.3 million (Q1 2025).